Precision BioSciences Inc (DTIL)
7.60
-0.10
(-1.30%)
USD |
NASDAQ |
Nov 15, 11:55
Precision BioSciences Free Cash Flow (Quarterly): -5.976M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -5.976M |
| June 30, 2024 | -14.90M |
| March 31, 2024 | -19.07M |
| December 31, 2023 | -8.418M |
| September 30, 2023 | -23.53M |
| June 30, 2023 | -22.26M |
| March 31, 2023 | -32.18M |
| December 31, 2022 | -22.48M |
| September 30, 2022 | 28.10M |
| June 30, 2022 | -25.00M |
| March 31, 2022 | -29.69M |
| December 31, 2021 | -25.19M |
| September 30, 2021 | -25.39M |
| June 30, 2021 | -33.03M |
| Date | Value |
|---|---|
| March 31, 2021 | 66.95M |
| December 31, 2020 | -14.55M |
| September 30, 2020 | -23.27M |
| June 30, 2020 | -27.59M |
| March 31, 2020 | -27.01M |
| December 31, 2019 | -26.08M |
| September 30, 2019 | -19.90M |
| June 30, 2019 | -24.71M |
| March 31, 2019 | -24.99M |
| December 31, 2018 | -22.78M |
| September 30, 2018 | -19.11M |
| June 30, 2018 | -10.44M |
| March 31, 2018 | -15.07M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-33.03M
Minimum
Jun 2021
66.95M
Maximum
Mar 2021
-15.53M
Average
-23.40M
Median
Free Cash Flow (Quarterly) Benchmarks
| Assembly Biosciences Inc | -17.12M |
| TG Therapeutics Inc | -12.23M |
| Protagonist Therapeutics Inc | -28.64M |
| Alector Inc | -50.95M |
| Entrada Therapeutics Inc | -24.90M |